CompletedNCT01979133
Icariin for Depression in Bipolarity With Co-Occurring Substance Use
About this title
Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
Read the official source — NCT01979133Medication studyAges 18–70United States
Understand this study
Who was this study for?
Listed age limits: 18 years to 70 years.
- Listed locations
- DallasSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateOctober 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 10
- Sponsor
- University of Texas Southwestern Medical Center
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 70 Years
- Official registry ID
- NCT01979133
- Official title
Show the full official title
A Proof of Concept Study of Icariin for Bipolar Disorder and Co-Occurring Substance Use Disorders
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Dallas
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Texas Southwestern Medical Center, a university.
Did this study involve medication?
Yes. The study involved medication, including Icariin.
Who was this study for?
Listed age limits: 18 years to 70 years.
